Status:
COMPLETED
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
Lead Sponsor:
Alcon Research
Conditions:
AMD
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients w...
Eligibility Criteria
Inclusion
- AMD disease
Exclusion
- Age
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
End Date :
December 1 2001
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00346866
Start Date
May 1 2000
End Date
December 1 2001
Last Update
August 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facility
Beachwood, Ohio, United States, 44122